Curium Pharma

Join us on 4th November, 2025 from 5:30–6:30pmCET for session 1 of our CME-accredited educational series on PSMA PET/CT in prostate cancer management.    This interactive, case-based webinar brings together a multidisciplinary panel of prostate cancer experts, including Prof. Harun Ilhan, Prof. Gianluca Giannarini, and Prof. Piet Ost, who will guide the audience through real-world diagnostic and therapeutic decision points.   Participants will engage in live case voting, explore clinical applications of PSMA PET, and earn UEMS-EACCME® Continuing Medical Education credits, recognized across 28 countries.    Stay at the forefront of multidisciplinary prostate cancer care and register today to secure your place.    Register here: https://lnkd.in/dB7E8WZw   #PSMAPET #ProstateCancer #NuclearMedicine #Oncology #Radiology #Urology #RadiationOncology #MedicalEducation #CME #EACCME #MolecularImaging #PrecisionMedicine #Curium #Webinar 

Two weeks have passed since the European Association of Nuclear Medicine (EANM) congress, yet the sense of connection and inspiration remains strong. As Marina Hodolic, Senior Director Medical Affairs at Curium, shared: “Being at EANM, meeting people face-to-face every day, exchanging ideas, learning, and collaborating… truly felt like coming home. This is the home of Medical Affairs.” With over 8,000 participants and 160 scientific sessions, EANM once again brought together the brightest minds in nuclear medicine. It was a privilege to connect with our peers, celebrate innovation, and continue advancing care for patients worldwide. #EANM2025 #Curium #NuclearMedicine #Radiopharmaceuticals #RadioligandTherapy #MedicalAffairs

Join Curium at NANETS 2025, October 23–25, in Austin, TX Visit our booth to explore Curium’s unbroken commitment to redefining the cancer experience. Building on a legacy in nuclear medicine, we’re shaping the future of theranostics through development of precision imaging and radioligand therapies that can help improve the lives of patients with cancer. Let’s work together to move theranostics forward. #Curium #NuclearMedicine #Theranostics #NANETS #NANETS2025

At this year’s European Association of Nuclear Medicine (EANM) Congress, Antoine Jacques, Director of Operational Marketing, reflected on what sets Curium apart from our competitors as we get closer to launching our radioligand therapy (RLT) for patients with prostate cancer.     Shaping the future of nuclear medicine, together.    #EANM2025 #Curium #NuclearMedicine #Radiopharmaceuticals

Join the Curium Symposium at NANETS 2025 on Friday, October 24, 2025, 6:00–7:30 pm CDT, to hear how precision PET/CT imaging is helping to shape clinical decisions in NET management. Our two guest speakers are Andreas Kjaer, MD, PhD, Chief Physician at Copenhagen University Hospital and Professor at the University of Copenhagen, and Simron Singh, MD, MPH, Medical Oncologist at Sunnybrook Odette Cancer Center and Professor at the University of Toronto. #Curium #NANETS #NANETS2025 #neuroendocrinetumors #NETs

Curium Group's CEO, Renaud. Dehareng, has been named one of The 10 Most Influential People in Healthcare to Watch in 2025 by CIO Views Magazine.   In this feature, Renaud reflects on his journey, Curium’s purpose to transform patient care, and our bold mission to advance both diagnosis and therapy in oncology. Read more about his inspiring leadership and vision here: Renaud Dehareng: https://lnkd.in/dp9ARVXu #Curium #Leadership #NuclearMedicine #Radiopharmaceuticals #Oncology #HealthcareInnovation #CIOViews

Curium, PeptiDream Inc. & PDRadiopharma Inc. Launch Registrational Trial in Japan    We’re excited to announce the first patient enrolled in a Phase 2 registrational trial of 64Cu-PSMA-I&T, a PET radiopharmaceutical targeting prostate cancer.    This milestone strengthens our collaboration with PeptiDream and PDRadiopharma to advance innovative radiopharmaceuticals and improve care for prostate cancer patients in Japan.    Read full Press Release: https://lnkd.in/dZAB_aqJ   #Curium #TeamCurium #EmployeeSpotlight #TogetherWeCan #NuclearMedicine #CareerGrowth

Curium’s Prague office officially reopens.  The beautifully redesigned space is bright, modern, and built for collaboration with open work areas, quiet zones, and comfortable breakout spaces that reflect our commitment to flexibility, connection, and creativity. To celebrate the reopening, the team hosted a vibrant launch event complete with a ribbon-cutting ceremony, local folk music, and plenty of great food and conversation. A huge thank you to everyone who made this project possible. We can’t wait to see the Prague team – and visiting colleagues – thrive in this beautiful new environment. #PragueOffice #WorkplaceDesign #TeamCulture #OfficeReopening #Collaboration #HybridWork

Life Science Leader recently featured Curium's partnership with RadioMedix as a fantastic example of how to effectively commercialise radiopharmaceuticals so more patients can access them. The article features Michael Patterson, CEO Curium North America and a fantastic quote from RadioMedix CEO Ebrahim Delpassand, M.D.: "Developing a drug is one thing, but navigating insurance companies, third party payers, contracting with them, having a strategy in terms of public awareness of the product, as well as then manufacturing and making sure that you can deliver in the commercial phase … it’s a totally different ballgame than, say, making a drug for an investigational trial. Curium already had 'boots on the ground'...and helped to make the commercial launch a success, leading to Detectnet capturing more than 70% of the market.” Read the article here: https://lnkd.in/eaPnpiHt

Employee Spotlight: Wiebke Röder Roeder, Senior Product Manager at Curium     Wiebke has worked with Curium products for nearly 15 years, and when the chance came to join the team, she “didn’t have to think twice.”    She describes Curium’s culture in three words: friendly, appreciative, and supportive — values reflected in every project, collaboration, and success.    “It’s a great feeling to work with such an open and supportive team. Everyone’s ideas are valued, and we keep learning together.”    We’re proud to have dedicated colleagues like Wiebke helping shape the future of nuclear medicine.     #Curium #TeamCurium #EmployeeSpotlight #TogetherWeCan #NuclearMedicine #CareerGrowth